FDA Adverse Event Injury Summary report: N

COMANECI EMBOLIZATION ASSIST DEVICE

MDR report key: 19641883 · Received July 1, 2024

Report

Report Number
3015531723-2024-00002
Event Type
Injury
Date Received
July 1, 2024
Date of Event
June 15, 2023
Report Date
July 1, 2024
Manufacturer
RAPID MEDICAL LTD
Product Code
PUU
UDI-DI
07290015107136
Adverse Event
Yes
Report Source
Distributor report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ACCORDING TO THE COMPLAINT DESCRIPTION, THERE'S NO INDICATION OF ANY DEVICE MALFUNCTION. EMBOLI FORMATION IS A KNOWN COMPLICATION OF WIDE NECK ANEURYSM EMBOLIZATION TREATMENTS WITH ASSIST DEVICES. NO CORRECTIVE ACTIONS ARE REQUIRED.

Description of Event or Problem · 0

THE FOLLOWING EVENT WAS REPORTED IN THE SUCCESS POST-MARKET SURVEILLANCE STUDY INVOLVING A 65-YEAR-OLD MALE WITH A HISTORY OF HYPERTENSION AND MIGRAINES. HE WAS TREATED WITH THE COMANECI AND ATLAS STENT FOR A RIGHT POSTERIOR COMMUNICATING ARTERY ANEURYSM ON (B)(6) 2023. ON (B)(6) 2023, THE PATIENT EXPERIENCED LEFT UPPER EXTREMITY WEAKNESS AND DYSMETRIA, LEADING TO HOSPITAL ADMISSION. AN MRI REVEALED MULTIPLE ACUTE CEREBROVASCULAR ACCIDENT (CVA) AREAS, PREDOMINANTLY IN THE RIGHT BILATERAL WATERSHED DISTRIBUTION. THE PATIENT CONTINUED DUAL ANTIPLATELET THERAPY AND STATIN TREATMENT. NEUROLOGY SUGGESTED A LOOP RECORDER IMPLANT AND TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE) FOR FURTHER EMBOLIC SOURCE EVALUATION. THE PATIENT UNDERWENT LINQ PLACEMENT AND TEE, WHICH SHOWED NO PATHOLOGY TO EXPLAIN THE CVA. CARDIOLOGY RECOMMENDED FOLLOW-UP IN ONE WEEK. THE PATIENT WAS DISCHARGED ON (B)(6) 2023, WITH FOLLOW-UPS SCHEDULED WITH HIS PRIMARY CARE PHYSICIAN AND CARDIOLOGY. THE EVENT WAS RESOLVED WITHOUT SEQUELAE ON JUNE 19, 2023.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2192806 COMANECI EMBOLIZATION ASSIST DEVICE COMANECI PUU RAPID MEDICAL LTD ANPP7177 230212CC01 07290015107136

Patients

Seq Age Sex Outcome Treatment
1 65 YR Male Required Intervention